Docoh
Loading...

CL Colgate-Palmolive

Filed: 29 Oct 21, 8:00am
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC  20549
________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) October 29, 2021

COLGATE-PALMOLIVE COMPANY
 (Exact name of registrant as specified in its charter)

Delaware
1-644
13-1815595
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)

300 Park Avenue, New York, New York10022
(Address of Principal Executive Offices)(Zip Code)

Registrant’s telephone number, including area code (212) 310-2000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
 Trading Symbol(s)
 
Name of each exchange on which
registered
Common Stock, $1.00 par value
 CL
 New York Stock Exchange
0.500% Notes due 2026
 CL 26
 New York Stock Exchange
1.375% Notes due 2034
 CL 34
 New York Stock Exchange
 0.875% Notes due 2039  CL 39 New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 2.02.Results of Operations and Financial Condition.

On October 29, 2021, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter ended September 30, 2021.  This press release is attached as Exhibit 99 and is incorporated herein by reference.

The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section.  The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.


Item 9.01.Financial Statements and Exhibits.


(d)
Exhibits.  The following exhibits are filed with this document:


Exhibit NumberDescription


99Press release, dated October 29, 2021, issued by Colgate-Palmolive Company


104Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
COLGATE-PALMOLIVE COMPANY
 
 
 
 
 
 
 
 
 
Date:  October 29, 2021
By:
/s/ Stanley J. Sutula III
 
 
Name:   Stanley J. Sutula III
 
 
Title:     Chief Financial Officer
 

3

EXHIBIT INDEX


Exhibit NumberDescription


99


104Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document)


4